Penumbra, Inc. (NYSE:PEN) Shares Purchased by O Shaughnessy Asset Management LLC

O Shaughnessy Asset Management LLC boosted its position in Penumbra, Inc. (NYSE:PEN) by 37.6% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,313 shares of the company’s stock after purchasing an additional 359 shares during the quarter. O Shaughnessy Asset Management LLC’s holdings in Penumbra were worth $312,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. HighTower Advisors LLC raised its position in shares of Penumbra by 2.3% in the third quarter. HighTower Advisors LLC now owns 5,792 shares of the company’s stock valued at $1,128,000 after buying an additional 128 shares during the last quarter. Quantinno Capital Management LP acquired a new stake in Penumbra in the 3rd quarter valued at about $294,000. XTX Topco Ltd lifted its stake in Penumbra by 70.7% in the 3rd quarter. XTX Topco Ltd now owns 2,680 shares of the company’s stock worth $521,000 after purchasing an additional 1,110 shares in the last quarter. Barclays PLC boosted its holdings in shares of Penumbra by 16.5% during the 3rd quarter. Barclays PLC now owns 18,025 shares of the company’s stock worth $3,502,000 after purchasing an additional 2,559 shares during the last quarter. Finally, M&T Bank Corp grew its position in shares of Penumbra by 14.1% in the third quarter. M&T Bank Corp now owns 1,445 shares of the company’s stock valued at $281,000 after purchasing an additional 179 shares in the last quarter. Hedge funds and other institutional investors own 88.88% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on PEN. Canaccord Genuity Group boosted their price objective on Penumbra from $323.00 to $340.00 and gave the stock a “buy” rating in a research note on Wednesday, February 19th. UBS Group boosted their price target on shares of Penumbra from $305.00 to $320.00 and gave the company a “buy” rating in a research report on Wednesday, February 19th. Bank of America initiated coverage on shares of Penumbra in a research report on Friday, March 14th. They set a “buy” rating and a $320.00 price objective for the company. Wells Fargo & Company boosted their target price on shares of Penumbra from $275.00 to $305.00 and gave the company an “overweight” rating in a report on Wednesday, February 19th. Finally, Needham & Company LLC restated a “hold” rating on shares of Penumbra in a report on Wednesday, February 19th. Four analysts have rated the stock with a hold rating, thirteen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $293.80.

Insiders Place Their Bets

In related news, EVP Johanna Roberts sold 600 shares of Penumbra stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $287.43, for a total value of $172,458.00. Following the completion of the transaction, the executive vice president now owns 66,539 shares in the company, valued at $19,125,304.77. The trade was a 0.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Adam Elsesser sold 16,565 shares of the business’s stock in a transaction that occurred on Wednesday, April 2nd. The stock was sold at an average price of $272.24, for a total transaction of $4,509,655.60. Following the transaction, the chief executive officer now owns 52,495 shares of the company’s stock, valued at $14,291,238.80. This trade represents a 23.99 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 111,236 shares of company stock worth $31,222,390 over the last 90 days. Corporate insiders own 5.00% of the company’s stock.

Penumbra Price Performance

PEN opened at $272.44 on Friday. The stock’s 50-day moving average price is $274.33 and its 200 day moving average price is $248.80. Penumbra, Inc. has a 12-month low of $148.00 and a 12-month high of $310.00. The firm has a market cap of $10.54 billion, a price-to-earnings ratio of 801.28, a PEG ratio of 2.83 and a beta of 0.56. The company has a current ratio of 6.01, a quick ratio of 3.25 and a debt-to-equity ratio of 0.02.

Penumbra (NYSE:PEN) last issued its quarterly earnings results on Tuesday, February 18th. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.88 by $0.09. The business had revenue of $315.52 million for the quarter, compared to analysts’ expectations of $311.63 million. Penumbra had a net margin of 1.17% and a return on equity of 9.74%. As a group, sell-side analysts expect that Penumbra, Inc. will post 3.67 earnings per share for the current year.

Penumbra Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.